台股 » 個股 » 昇陽 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

昇陽

(3266)
可現股當沖
  • 股價
    24.35
  • 漲跌
    --
  • 漲幅
    0.00%
  • 成交量
    597
  • 產業
    上市 營建類股
  • 34人加入追蹤

    立即追蹤

  • 本地時間:13:35(已收盤)

     
昇陽 (3266)籌碼相關-永豐金-中壢 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

永豐金-中壢 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/05/16122.9000.0023.4011,3410.07%
2024/05/15123.2000.0022.9511,3380.07%
2024/05/1000.002024.2324.00-201,282-1.56%
2024/05/03224.80225.2525.6001,0800.00%
2024/04/302322.87322.7522.60208362.39%
2024/03/2100.001518.0017.90-15508-2.95%
2024/03/201517.9000.0018.00155162.91%
2024/03/1200.00918.8718.40-9751-1.20%
2024/03/06121.7000.0021.3016940.14%
2024/02/1900.00220.2020.25-2820-0.24%
2024/02/16519.5000.0019.7558030.62%
2024/01/1100.00419.8519.45-4725-0.55%
2024/01/09419.69419.6319.5007130.00%
2024/01/0300.00119.9519.65-1684-0.15%
2023/12/2900.00119.1019.05-1662-0.15%
2023/12/22118.6500.0018.6516470.15%
2023/12/19118.85119.2019.3006220.00%
2023/12/15319.60319.6019.6005970.00%
2023/12/14319.40219.6019.4015870.17%
2023/12/1300.00119.6519.35-1561-0.18%
2023/12/12620.58120.4519.8055230.96%
2023/11/2400.002017.0617.10-20248-8.04%
2023/11/20317.1500.0017.1531232.43%
2022/05/03114.55114.3513.9506990.00%
2022/04/2500.00513.9013.90-5663-0.75%
2022/04/22514.9000.0014.5056480.77%
2022/04/2000.001014.8014.50-10618-1.62%
2022/04/1900.00114.9514.70-1613-0.16%
2022/04/18114.90215.7014.85-1590-0.17%
2022/04/151116.3200.0016.45115412.03%
2022/04/14116.95216.2316.55-1499-0.20%
2022/04/13516.58516.3716.5004560.00%
2022/04/12215.55116.3516.6513410.29%
2022/04/11315.1200.0015.1531831.63%
2021/06/2300.00112.7012.70-1169-0.59%
2021/06/17112.5500.0012.5511730.58%
2020/04/2000.00111.9012.00-1198-0.50%
2020/04/13111.9000.0012.0011580.63%
2019/11/0600.00115.5515.80-1421-0.24%
2019/11/0400.00115.7015.90-1421-0.24%
2019/10/31216.1500.0015.9524240.47%
2019/08/21113.10113.4513.4502100.00%
2019/08/20313.80313.7813.7501980.00%
2018/09/05212.10212.3511.8503560.00%
2018/06/22113.00112.8012.3001350.00%
昇陽半攻先進製程、先進封裝 明年營運勝今年Anue鉅亨-2023/12/24
昇陽半生技布局報捷 多合一液態蛋白檢測平台完成臨床前測試Anue鉅亨-2023/12/21
昇陽 相關文章